|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 276, Issue 7, 4756-4765, February 16, 2001
From the Department of Experimental Pathology and Oncology of
Florence University, Viale G. B. Morgagni 50, 50134 Florence, Italy
We show here that the interaction between the
urokinase-type plasminogen activator and its receptor, which plays a
critical role in cell invasion, is regulated by heparan sulfate present on the cell surface and in the extracellular matrix. Heparan sulfate oligomers showing a composition close to the dimeric repeats of heparin
(glucosamine-NSO3(6-OSO3)-iduronic
acid(2-OSO3)) n = 5 and n > 5, where iduronic acid may alternate with glucuronic acid, exhibit
affinity for urokinase plasminogen activator and confer specificity on
urokinase/urokinase receptor interaction. Cell surface clearance of
heparan sulfate reduces the affinity of such interaction with a
parallel decrease of specific urokinase binding in the presence of an
unaltered expression of receptor. Transfection of human urokinase
plasminogen activator receptor in normal Chinese hamster ovary
fibroblasts and in Chinese hamster ovary cells defective for the
synthesis of sulfated glycosaminoglycans results in specific urokinase/receptor interaction only in nondefective cells. Heparan sulfate/urokinase and receptor/urokinase interactions exhibit similar
Kd values. We concluded that heparan sulfate functions as an adaptor molecule that confers specificity on
urokinase/receptor binding.
To whom correspondence may be addressed: Dept. of Experimental
Pathology and Oncology, University of Florence, Viale G.B. Morgagni
50-50134 Florence, Italy. Tel.: 39-55-414814; Fax: 39-55-416908; E-mail: delrosso@unifi.it.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc. This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||